TrialThe Lancet. Oncology2018
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.
Eric Jonasch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
58 papers cite it
this paperpooled ittrialcites it